Corporate Symposium on Challenges in Global Health—New Opportunities for the Private Sector

July 27, 2010
Tokyo
Leading members of the corporate, philanthropic, and health sectors gathered in Tokyo on July 27, 2010, for a JCIE symposium entitled “Challenges in Global Health: New Opportunities for the Private Sector.” Primarily targeting corporate executives in Japan, the discussion at the day-long symposium was aimed at exploring ways for Japanese corporations to play a key role in addressing global health challenges by effectively enhancing their own potential to engage with international organizations working in the field. Prominent global health experts in Japan made brief remarks on the state of global health and Japan’s growing role in the field. Following their remarks, representatives from four major international organizations—the Global Fund to Fight AIDS, Tuberculosis and Malaria; the Global Alliance for Vaccines and Immunization; the Global Alliance for Improved Nutrition; and the Drugs for Neglected Diseases initiative—introduced their organizations’ goals and approaches, provided examples of ongoing partnerships with the private sector, and suggested other forms of partnership that companies might consider. In the afternoon, panelists from a broad range of Japanese companies—from pharmaceutical and chemical companies to an investment firm—shared their own experiences partnering with international organizations in the global health field, with a focus on why companies engaged, how they made the decision to enter into a partnership, and the impact the partnerships have had on their companies. Representatives from more than 70 companies in Japan gained exposure to the many opportunities for partnership in the global health field through their participation in the symposium.
From left: Mr. Akira Kojima (moderator), Mr. Toshio Arima, Mr. Tatsuo Mizuno and Mr. Hiroshi Ohtsuk

PRESENTATIONS

Opening Session: Japan’s Contribution to Global Health—What is Our Potential?

KIYOSHI KUROKAWA | Professor, National Graduate Institute for Policy Studies; Chairman, Health Policy Institute, Japan

GLOBAL HEALTH & HUMAN SECURITY

KEIZO TAKEMI | Chair, Global Health & Human Security Program; Professor, Tokai University; Senior Fellow, Japan Center for International Exchange (JCIE)

 Session 1: New Global Heath Initiatives and Partnership with the Private Sector 

GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

STEFAN EMBLAD | Director, Resource Mobilization, the Global Fund to Fight AIDS, Tuberculosis and Malaria

GLOBAL ALLIANCE FOR VACCINES AND IMMUNISATION (GAVI ALLIANCE)

JOELLE TANGUY | Managing Director, GAVI Alliance

GLOBAL ALLIANCE FOR IMPROVED NUTRITION (GAIN)

MICHAEL MADNICK | Deputy Executive Director, GAIN

DRUGS FOR NEGLECTED DISEASES iNITIATIVE (DNDi)

JEAN-PIERRE PACCAUD | Director of Business Development, DNDi

Session 2: Innovative Ways for Corporations to Tackle Global Health Challenges

OVERVIEW

RECENT TRENDS IN GLOBAL CORPORATIONS CONTRIBUTING TO THE MDGs

TOSHIO ARIMA | Chairman, Global Compact Board Japan; Executive Corporate Advisor, Fuji Xerox Company Limited

CASES

FIGHTING MALARIA THROUGH OLYSET®  NET

TATSUO MIZUNO |  General Manager, Vector Control Division, Sumitomo Chemical Company Limited 

ENDOWMENT PROGRAM FOR THE GLOBAL FUND WITH THE GOAL OF STRENGTHENING HUMAN RESOURCES AND HEALTH CARE

HIROSHI OHTSUKI |  Corporate Officer, General Manager, Takeda Pharmaceutical Company Limited 

CONTRIBUTIONS TO GLOBAL HEALTH THROUGH INITIATIVES BY FOOD COMPANIES TO IMPROVE NUTRITION

SATOSHI KITAMURA |  Corporate Citizenship Manager, CSR Department, Ajinomoto Co., Inc.

LEVERAGING FINANCIAL CAPABILITY FOR IMMUNIZATION: IFFIm “VACCINE BONDS” PROVES OPPORTUNITIES FOR THE PRIVATE SECTOR

SATORU YAMAMOTO |  Deputy General Manager, Product Planning Department, Daiwa Securities Co. Ltd. 

LEVERAGING FINANCIAL CAPABILITY FOR IMMUNIZATION: IFFIm “VACCINE BONDS” PROVES OPPORTUNITIES FOR THE PRIVATE SECTOR

SATORU YAMAMOTO |  Deputy General Manager, Product Planning Department, Daiwa Securities Co. Ltd. 

ENHANCING LOCAL MANUFACTURING CAPACITY: PHARMACEUTICALS AND QUALITY CONTROL

KENJI TODA |  Deputy Director General, International Federation of Pharmaceutical Manufactures & Associations; Senior Vice President, Government Relations, Eisai Company Limited